Metastatic Cervical Cancer Recruiting Phase 2 Trials for Dostarlimab (DB15627)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06238635Dostarlimab and Cobolimab in Advanced Cervical CancerTreatment